United States securities and exchange commission logo





                              November 17, 2022

       Christopher Hogan
       Interim Chief Executive Officer
       NYIAX, INC.
       180 Maiden Lane, 11th Floor
       New York, NY 10005

                                                        Re: NYIAX, INC.
                                                            Amendment No. 1 to
Registration Statement on Form S-1
                                                            Filed October 20,
2022
                                                            File No. 333-265357

       Dear Christopher Hogan:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our June
29, 2022 letter.

       Amendment No.1 to Registration Statement on Form S-1

       Risk Factors, page 8

   1.                                                   We note recent
instances of extreme stock price run-ups followed by rapid price declines
                                                        and stock price
volatility seemingly unrelated to company performance following a
                                                        number of recent
initial public offerings, particularly among companies with relatively
                                                        smaller public floats.
Revise to include a separate risk factor addressing the potential for
                                                        rapid and substantial
price volatility and any known factors particular to your offering that
                                                        may add to this risk
and discuss the risks to investors when investing in stock where the
                                                        price is changing
rapidly. Clearly state that such volatility, including any stock-run up,
                                                        may be unrelated to
your actual or expected operating performance and financial
                                                        condition or prospects,
making it difficult for prospective investors to assess the rapidly
 Christopher Hogan
FirstName LastNameChristopher Hogan
NYIAX, INC.
Comapany 17,
November   NameNYIAX,
              2022       INC.
November
Page 2    17, 2022 Page 2
FirstName LastName
         changing value of your stock.
2.       In light of your commercial relationship with Nasdaq and the fact you
intend to list your
         shares on the Nasdaq Capital Market, please consider including a risk
factor discussing
         risks resulting from any conflicts of interest or the appearance of
conflicts of interest.
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Results of Operations, page 30

3.       In regard to your result of operations for the years ended December
31, 2021 and 2020,
         and elsewhere as appropriate, please label each column of the
corrected financial
         statements as    restated.
Going Concern, Liquidity and Capital Resources, page 32

4.       We note your response to prior comment 2. We also note your disclosure
that
         management believes that the existing cash as of June 30, 2022 will
not be sufficient to
         fund operations for at least the next 12 months. Please disclose the
minimum number of
         months that you will be able to conduct your planned operations using
currently available
         capital resources. Refer to Item 303(b)(1) and Section IV of SEC
Release No. 33-8350 for
         additional guidance.
Restatements, page 35

5.       We note that your financial statements were restated. Please tell us
whether a material
         weakness was identified, and if so, include a risk factor describing
any material
         weaknesses, the resulting restatement, and any associated remediation
procedures and the
         related time frame.
General

6.       Please tell us whether you are required to have a qualified
independent underwriter in
         light of the potential conflicts of interest of your underwriter, West
Park Capital, pursuant
         to FINRA Rule 5121. If so, please revise to add appropriate risk
factor disclosure.
        You may contact Joseph Cascarano, Senior Staff Accountant, at
202-551-3376 or Lisa
Etheredge, Senior Staff Accountant, at 202-551-3424 if you have questions
regarding comments
on the financial statements and related matters. Please contact Kyle Wiley,
Staff Attorney, at
202-344-5791 or Mitchell Austin, Staff Attorney, at 202-551-3574 with any other
questions.
 Christopher Hogan
NYIAX, INC.
November 17, 2022
Page 3

                                      Sincerely,
FirstName LastNameChristopher Hogan
                                      Division of Corporation Finance
Comapany NameNYIAX, INC.
                                      Office of Technology
November 17, 2022 Page 3
cc:       Mitchell Lampert
FirstName LastName